comprehensive -WSS

comprehensive

author：hotspot 2025-09-29 07:50:05 - browse：69

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

Readout Newsletter: Bluebird, CVS, Contineum

Creating egg and sperm cells from stem cells raises ethical issues

Some dementia cases could be undiagnosed liver disease

Vertex non

Even great ERs can’t make up for American health disparities

Virtual Event: March of the Biosimilars

hotspot

comprehensive

Sponsor introduction

Featured speakers

Sponsored By

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Vertigo drug brings hope for rare neuron disorder, Niemann

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Health AI adoption puts security, privacy startups on investors' radar

Continuity nursing helped my family in our darkest PICU moments

FDA drug safety: Singulair case shows systemic surveillance flaws

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New Ultima Genomics DNA sequencer can read genome for $100

Wikipedia

Physicians and social media: If you see something, say something?

What we need to know about Arena Bioworks

Medicare drug price negotiation’s day in court

Apple Vision Pro: A first look at health apps on the new VR headset

Juul spent big to court Black leaders to promote its e

AstraZeneca to buy developer of next

entertainment

knowledge

focus

focus